Skip to Main Content

Cassava Sciences, Inc. (NASDAQ: SAVA) Securities Fraud Class Action

COMPANY       Cassava Sciences, Inc.
COURT United States District Court for the Western District of Texas
CASE NUMBER 24-cv-01525
JUDGE The Honorable David A. Ezra
CLASS PERIOD  October 13, 2023 through March 25, 2025
SECURITY TYPE  Securities

Case Background:

This is a securities fraud class action lawsuit on behalf of those who purchased or otherwise acquired Cassava Sciences Inc. (“Cassava”) (NASDAQ: SAVA) securities between October 13, 2023 through March 25, 2025, inclusive (the “Class Period”). 

The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects.  Specifically, Defendants misrepresented and/or failed to disclose that: (1) Cassava’s drug, simufilam, was not capable of abating the progression of Alzheimer’s Disease, even in mild to moderate cases; and (2) as a result, Defendants’ statements about the company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Current Status of Case:

On August 25, 2025, Plaintiffs filed an Amended Complaint. This action is ongoing.

If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.

Complete this form with your transactions in Cassava Sciences, Inc. securities between October 13, 2023 and March 25, 2025..

Click Here to Print PDF of this Form

SUBMIT YOUR INFORMATION
* Denotes required field
Date
# of Shares
Price per Share
Date
Principal Amount
Amount Paid
Series or CUSIP
Date
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of Cassava Sciences, Inc. (2024) prior to the Class Period?
Are you a current or former employee of Cassava Sciences, Inc. (2024)?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC disclaimer
I would like to receive new case alerts by email